Reaching the best-seller status in this category on Amazon.com within months of launch is evidence of the rate of growth of Else Nutrition’s cereal offering, also is the U.S. first Clean Label Purity Award Certified Baby Cereal – validated to be safe from heavy metals
VANCOUVER, BC, September 15, 2022 – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), announces that Else Nutrition Super Cereal for babies has reached the number one best sellers rank for all baby cereals within months of its launch. Unlike the New Releases category, this ranks best-selling products across all brands on the Amazon.com platform.
“While we’ve reached best-seller status for Else products in the past in the New Releases category, this is the first time one of our products outranks all other competitors within a category on Amazon.com. This confirms parents desire a plant-based baby cereal that is nutritionally balanced, providing all macronutrients and essential vitamins and minerals,” said Hamutal Yitzhak, CEO, and Co-Founder of Else Nutrition.
Else Super Cereal is the first baby cereal in the U.S. to be awarded the Clean Label Purity Award which certifies that it is safe from heavy metals, pesticides, and other contaminants. It has also received the Climate Pledge Friendly seal from Amazon as a reflection of the company’s commitment to sustainability.
“We are proud of the feedback we receive from customers about our cereal, whether from parents looking for an alternative or those feeding baby their first solid food. And with the recent focus on heavy metal levels in baby food, we are even more excited about being the first-ever baby cereal certified safe from heavy metals in the U.S., and look forward to welcoming many more parents and babies to the Else family.”
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at Milan’s Global Food Innovation Summit. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed on TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets Q.X. board under the trading symbol BABYF and the Frankfurt Exchange under the symbol 0YL. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents and gained national retailer support from Sprouts Farmers Market, and achieved rapid sales growth. Else became the #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category. It recently won the ‘Best Dairy Alternative’ Award 2021 at World Plant-Based Expo and was a Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category.
Investor Relations Contact:
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: [email protected]
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.